Nomination Committee appointed in respect of AGM 2023 in Alligator Bioscience AB
Lund, Sweden, October 24, 2022– Alligator Bioscience (Nasdaq Stockholm: ATORX) today announces that the Nomination Committee in preparation ...
The Nomination Committee’s proposal regarding the Board of Directors ahead of the Annual General Meeting 2022 in Alligator Bioscience AB
REGULATORY 11 March 2022 Ahead of the Annual General Meeting in Alligator Bioscience AB on May 5, 2022, the Nomination Committee announces i ...
Nomination Committee Appointed in Respect of AGM 2022 in Alligator Bioscience AB
Lund, Sweden, January 20, 2021– Alligator Bioscience (Nasdaq Stockholm: ATORX) Alligator Bioscience (Nasdaq Stockholm: ATORX), announces tod ...
Nomination Committee appointed in respect of AGM 2022 in Alligator Bioscience AB
Lund, Sweden, November 3, 2021– Alligator Bioscience (Nasdaq Stockholm: ATORX) today announces that the Nomination Committee in preparation ...
The Nomination Committee’s proposal regarding the board of directors ahead of the annual general meeting 2021 in Alligator Bioscience AB
Ahead of the annual general meeting in Alligator Bioscience AB on June 1, 2021, the Nomination Committee announces its proposals regarding C ...
Nomination Committee appointed in respect of AGM 2021 in Alligator Bioscience AB
Lund, Sweden, November 20, 2020 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announces that the Nomination Committee in preparatio ...
Nomination Committee appointed in respect of AGM 2020 in Alligator Bioscience AB
Lund, Sweden, November 13, 2019 – Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmace ...
The Nomination Committee’s proposal for the annual shareholders’ meeting in Alligator Bioscience AB (publ)
Lund, Sweden, April 17, 2019 – Alligator Bioscience (Nasdaq Stockholm: ATORX), today announces that the Nomination Committee in Alligator Bi ...
Nomination Committee appointed in respect of AGM 2019 in Alligator Bioscience AB
Lund, Sweden, November 6, 2018 – Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceu ...